Bite-on-bite biopsies for the detection of residual esophageal cancer after neoadjuvant chemoradiotherapy.

Autor: van der Bogt RD; Department of Gastroenterology and Hepatology, Erasmus Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van der Wilk BJ; Department of Surgery, Erasmus Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Oudijk L; Department of Pathology, Erasmus Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Schoon EJ; Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., van Lijnschoten G; Department of Pathology, Stichting PAMM, Eindhoven, The Netherlands., Corporaal S; Department of Gastroenterology and Hepatology, Leeuwarden Medical Center, Leeuwarden, The Netherlands., Nieken J; Department of Pathology, Pathology Friesland, Leeuwarden, The Netherlands., Siersema PD; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., Bisseling TM; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Post RS; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Quispel R; Department of Gastroenterology and Hepatology, Reinier de Graaf Hospital, Delft, The Netherlands., van Tilburg A; Department of Pathology, Reinier de Graaf Hospital, Delft, The Netherlands., Oostenbrug LE; Department of Gastroenterology and Hepatology, Zuyderland Medical Center, Heerlen, The Netherlands., Riedl RG; Department of Pathology, Zuyderland Medical Center, Heerlen, The Netherlands., Hol L; Department of Gastroenterology and Hepatology, Maasstad Hospital, Rotterdam, The Netherlands., Kliffen M; Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands., Nikkessen S; Department of Gastroenterology and Hepatology, Erasmus Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Eyck BM; Department of Surgery, Erasmus Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van Lanschot JJB; Department of Surgery, Erasmus Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Doukas M; Department of Pathology, Erasmus Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Endoscopy [Endoscopy] 2022 Dec; Vol. 54 (12), pp. 1131-1138. Date of Electronic Publication: 2022 Jun 03.

An Extraosseous Ewing Sarcoma of the Index Finger Masquerading as a Benign Tumor.

Autor: Wolthuizen R; Medical Center Leeuwarden, The Netherlands. Electronic address: roosjewolthuizen@hotmail.com., Nieken J; Department of Pathology, Pathology Friesland, Leeuwarden, The Netherlands., Overbosch J; Department of Radiology, University Medical Center Groningen, Groningen, The Netherlands., Pool SMW; Medical Center Leeuwarden, The Netherlands.

Publikováno v: The Journal of hand surgery [J Hand Surg Am] 2020 Apr; Vol. 45 (4), pp. 366.e1-366.e4. Date of Electronic Publication: 2019 Jul 18.

Fibrogenesis in Human Mucosa and Muscularis Precision-Cut Intestinal Slices.

Autor: Biel, Carin¹ (AUTHOR) c.biel@rug.nl, Kastermans, Anniek¹ (AUTHOR) c.henstra@rug.nl, Heidema, Janneke¹ (AUTHOR), Pehrsson, Martin² (AUTHOR) mpe@nordicbio.com, Henstra, Charlotte¹ (AUTHOR), Mortensen, Joachim² (AUTHOR) jhm@nordicbio.com, Faber, Klaas Nico³ (AUTHOR) k.n.faber@umcg.nl, Olinga, Peter¹ (AUTHOR) p.olinga@rug.nl

Publikováno v: Cells (2073-4409). Jul2024, Vol. 13 Issue 13, p1084. 17p.

RECOMBINANT HUMAN INTERLEUKIN-6 INDUCES A RAPID AND REVERSIBLE ANEMIA IN CANCER-PATIENTS

Autor: NIEKEN, J, MULDER, NH, VELLENGA, E, LIMBURG, PC, PIERS, DA, DEVRIES, EGE

Publikováno v: Blood, 86(3), 900-905. AMER SOC HEMATOLOGY

Initial studies have shown that recombinant human interleukin-6 (rhIL-6) induces anemia. Until now, the pathophysiologic mechanism of this induced anemia has been unknown. To unravel the underlying mechanism, we examined 15 cancer patients receiving

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::3ef107f098fc957f8a30a0af50f58eeb
https://research.rug.nl/en/publications/04c05c4b-1f33-4d86-aaf2-082e1a7ff090

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.